Ultrasound-Targeted Microbubble Destruction Enhances Inhibitory Effect of Apatinib on Angiogenesis in Triple Negative Breast Carcinoma Xenografts

Ultrasound-targeted microbubble destruction (UTMD) has been proven as an effective technique to assist drugs to cross the vascular wall and cell membrane. This study was aimed at evaluating the synergistic antiangiogenic and growth-inhibiting effects of apatinib (APA) and UTMD on the triple negative...

Full description

Saved in:
Bibliographic Details
Main Authors: Dengke Hong, Jiajia Yang, Jingjing Guo, Yu Zhang, Zhikui Chen
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2021/8837950
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850177403145420800
author Dengke Hong
Jiajia Yang
Jingjing Guo
Yu Zhang
Zhikui Chen
author_facet Dengke Hong
Jiajia Yang
Jingjing Guo
Yu Zhang
Zhikui Chen
author_sort Dengke Hong
collection DOAJ
description Ultrasound-targeted microbubble destruction (UTMD) has been proven as an effective technique to assist drugs to cross the vascular wall and cell membrane. This study was aimed at evaluating the synergistic antiangiogenic and growth-inhibiting effects of apatinib (APA) and UTMD on the triple negative breast cancer (TNBC). The TNBC xenograft model was established in nude mice (n=40) which were then randomly divided into the APA plus UTMD (APA-U) group, UTMD group, APA group, and model control (M) group (n=10 per group). Corresponding treatment was done once daily for 14 consecutive days. The general condition and body weight of tumor-bearing nude mice were monitored. Routine blood test and detection of liver and kidney function were done after treatments. The tumor size and microcirculation were examined by two-dimensional ultrasonography (2DUS) and contrast-enhanced ultrasonography (CEUS), respectively. Then, the tumor tissues were harvested for the detection of vascular endothelial growth factor (VEGF) by immunohistochemistry and for CD31-PAS double staining to assess microvessel density (MVD) and heterogeneous vascular positivity rate. After treatments, the tumor growth and angiogenesis were significantly inhibited in the APA group and the APA-U group, and these effects were more obvious in the APA-U group. The tumor volume, CEUS parameters, VEGF expression, and MVD in the APA-U group were significantly lower than those in the APA group (P<0.05), while there were no marked differences in the heterogeneous vascular positivity rate, body weight, and blood parameters between the two groups (P>0.05). In the UTMD group, the tumor growth and angiogenesis were not significantly inhibited, and all the parameters were similar to those in the M group (P>0.05). During the experiment, all mice survived and generally had good condition. In conclusion, APA combined with UTMD may exert synergistic antiangiogenic and growth-inhibiting effects on the TNBC and not increase the heterogeneous vasculature and the severity of APA-related systemic side effects.
format Article
id doaj-art-bf210f3a4ff849beb83a4cc99f32e65b
institution OA Journals
issn 2210-7177
2210-7185
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-bf210f3a4ff849beb83a4cc99f32e65b2025-08-20T02:18:58ZengWileyAnalytical Cellular Pathology2210-71772210-71852021-01-01202110.1155/2021/88379508837950Ultrasound-Targeted Microbubble Destruction Enhances Inhibitory Effect of Apatinib on Angiogenesis in Triple Negative Breast Carcinoma XenograftsDengke Hong0Jiajia Yang1Jingjing Guo2Yu Zhang3Zhikui Chen4Department of Vascular Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, ChinaDepartment of Ultrasound, Fujian Medical University Union Hospital, Fuzhou, Fujian, ChinaDepartment of Ultrasound, Fujian Medical University Union Hospital, Fuzhou, Fujian, ChinaDepartment of Ultrasound, Fujian Medical University Union Hospital, Fuzhou, Fujian, ChinaDepartment of Ultrasound, Fujian Medical University Union Hospital, Fuzhou, Fujian, ChinaUltrasound-targeted microbubble destruction (UTMD) has been proven as an effective technique to assist drugs to cross the vascular wall and cell membrane. This study was aimed at evaluating the synergistic antiangiogenic and growth-inhibiting effects of apatinib (APA) and UTMD on the triple negative breast cancer (TNBC). The TNBC xenograft model was established in nude mice (n=40) which were then randomly divided into the APA plus UTMD (APA-U) group, UTMD group, APA group, and model control (M) group (n=10 per group). Corresponding treatment was done once daily for 14 consecutive days. The general condition and body weight of tumor-bearing nude mice were monitored. Routine blood test and detection of liver and kidney function were done after treatments. The tumor size and microcirculation were examined by two-dimensional ultrasonography (2DUS) and contrast-enhanced ultrasonography (CEUS), respectively. Then, the tumor tissues were harvested for the detection of vascular endothelial growth factor (VEGF) by immunohistochemistry and for CD31-PAS double staining to assess microvessel density (MVD) and heterogeneous vascular positivity rate. After treatments, the tumor growth and angiogenesis were significantly inhibited in the APA group and the APA-U group, and these effects were more obvious in the APA-U group. The tumor volume, CEUS parameters, VEGF expression, and MVD in the APA-U group were significantly lower than those in the APA group (P<0.05), while there were no marked differences in the heterogeneous vascular positivity rate, body weight, and blood parameters between the two groups (P>0.05). In the UTMD group, the tumor growth and angiogenesis were not significantly inhibited, and all the parameters were similar to those in the M group (P>0.05). During the experiment, all mice survived and generally had good condition. In conclusion, APA combined with UTMD may exert synergistic antiangiogenic and growth-inhibiting effects on the TNBC and not increase the heterogeneous vasculature and the severity of APA-related systemic side effects.http://dx.doi.org/10.1155/2021/8837950
spellingShingle Dengke Hong
Jiajia Yang
Jingjing Guo
Yu Zhang
Zhikui Chen
Ultrasound-Targeted Microbubble Destruction Enhances Inhibitory Effect of Apatinib on Angiogenesis in Triple Negative Breast Carcinoma Xenografts
Analytical Cellular Pathology
title Ultrasound-Targeted Microbubble Destruction Enhances Inhibitory Effect of Apatinib on Angiogenesis in Triple Negative Breast Carcinoma Xenografts
title_full Ultrasound-Targeted Microbubble Destruction Enhances Inhibitory Effect of Apatinib on Angiogenesis in Triple Negative Breast Carcinoma Xenografts
title_fullStr Ultrasound-Targeted Microbubble Destruction Enhances Inhibitory Effect of Apatinib on Angiogenesis in Triple Negative Breast Carcinoma Xenografts
title_full_unstemmed Ultrasound-Targeted Microbubble Destruction Enhances Inhibitory Effect of Apatinib on Angiogenesis in Triple Negative Breast Carcinoma Xenografts
title_short Ultrasound-Targeted Microbubble Destruction Enhances Inhibitory Effect of Apatinib on Angiogenesis in Triple Negative Breast Carcinoma Xenografts
title_sort ultrasound targeted microbubble destruction enhances inhibitory effect of apatinib on angiogenesis in triple negative breast carcinoma xenografts
url http://dx.doi.org/10.1155/2021/8837950
work_keys_str_mv AT dengkehong ultrasoundtargetedmicrobubbledestructionenhancesinhibitoryeffectofapatinibonangiogenesisintriplenegativebreastcarcinomaxenografts
AT jiajiayang ultrasoundtargetedmicrobubbledestructionenhancesinhibitoryeffectofapatinibonangiogenesisintriplenegativebreastcarcinomaxenografts
AT jingjingguo ultrasoundtargetedmicrobubbledestructionenhancesinhibitoryeffectofapatinibonangiogenesisintriplenegativebreastcarcinomaxenografts
AT yuzhang ultrasoundtargetedmicrobubbledestructionenhancesinhibitoryeffectofapatinibonangiogenesisintriplenegativebreastcarcinomaxenografts
AT zhikuichen ultrasoundtargetedmicrobubbledestructionenhancesinhibitoryeffectofapatinibonangiogenesisintriplenegativebreastcarcinomaxenografts